Aktie A3CY3W GOOD WORKS II ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Good Works II Acquisition Corp.

Aktien

A3CY3W

US38216G1040

GWII

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Good Works II Acquisition Corp.(NasdaqCM:GWII) dropped from NASDAQ Composite Index
Good Works II Acquisition : Other Event - Form 8-K
GOOD WORKS II ACQUISITION CORP. : Other Events (form 8-K)
GOOD WORKS II ACQUISITION CORP. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Direct Biologics LLC cancelled the acquisition of Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others in a reverse merger transaction.
GOOD WORKS II ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
GOOD WORKS II ACQUISITION CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
GOOD WORKS II ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Good Works II Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Good Works II Acquisition, Direct Biologics Enter SPAC Merger Deal
Direct Biologics to list in U.S. via $1 billion SPAC
Good Works II Acquisition Corp. and Direct Biologics, LLC Announce a Definitive Agreement for a Business Combination
GOOD WORKS II ACQUISITION CORP. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Good Works II Acquisition Signs Letter of Intent for Business Combination With Direct Biologics
Good Works II Acquisition Corp. Announces Letter of Intent for a Business Combination with Direct Biologics, LLC
GOOD WORKS II ACQUISITION CORP. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors
Direct Biologics LLC entered into a non-binding letter of intent to acquire Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others for approximately $630 million in a reverse merger transaction.
GOOD WORKS II ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Good Works II Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CY3W Aktie
  4. Nachrichten Good Works II Acquisition Corp.
  5. Andere Sprachen